Andy Bruns represents clients in complex commercial litigation, including patent and intellectual property disputes, and white collar criminal defense. He has experience defending clients in the technology, life sciences, sports, and digital currency sectors in litigation arising in both state and federal courts, as well as in arbitration.
Andy has served as an active member of several trial teams, including representing the former CEO of Bumble Bee Foods in a five-week jury trial involving price-fixing allegations. He is also defending successive generations of Dexcom products in parallel cases where Abbott is asserting over a dozen patents targeting Dexcom’s continuous glucose monitoring technology for addressing diabetes. He is part of a Keker team representing Google against Singular in a two-patent trial in the District of Massachusetts related to specialized chips used for machine learning.
Andy maintains an active pro bono practice representing incarcerated individuals in resentencing proceedings. He has worked extensively with the Giffords Law Center on gun violence prevention initiatives, and has partnered with the ACLU and the National Association of Public Defense on amicus briefs before the U.S. and California Supreme Courts.
Prior to joining Keker, Van Nest & Peters, Andy served as a law clerk to Judge Rebecca Pallmeyer of the U.S. District Court for the Northern District of Illinois and Judge Ronald Gilman of the U.S. Court of Appeals for the Sixth Circuit. Andy earned his J.D. from Columbia Law School and his undergraduate degree from Amherst College.
Cases of Note
-
United States v. Christopher Lischewski
We defended the former CEO of Bumble Bee Foods in a five-week jury trial in the Northern District of California against charges that he conspired to fix prices of canned…
-
Daedalus Prime v. Google
We are defending Google against a five-patent case brought by Daedalus Prime in the Western District of Texas targeting alleged power-management functionalities in Google’s Tensor system-on-chip products and Axion processors.
-
Abbott Diabetes Care v. Dexcom
We defended Dexcom in the District of Delaware where Abbott asserted a dozen patents targeting Dexcom’s G6 continuous glucose monitoring technology. The Keker team narrowed the case to four patents…
News & Events
-
Law360 Trials Group Of The Year: Keker, Van Nest & Peters
Keker, Van Nest & Peters partners Bob Van Nest, Sharif Jacob, Sophie Hood and Ryan Wong reflect on the firm’s biggest trial wins which earned its place among Law360’s 2024 Trials Groups of the Year.
Read More -
Pro Bono Showcase: Keker Pursues Justice with Felony Murder Resentencing Project
In celebration of National Pro Bono Week, we highlight the firm’s Felony Murder Resentencing Project, which has helped at least six incarcerated individuals overturn their life sentences.
Read More -
Amicus Brief Supports Free-Speech Challenge to Online Age-Verification Law
Keker, Van Nest & Peters attorneys Andy Bruns, Imara McMillan, Amos Espeland, and Courtney Liss filed an amicus brief with the U.S. Supreme Court in a case challenging Texas’s HB 1181 online age-verification la…
Read More -
12-Patent Glucose Monitoring Lawsuit Ends with Jury Finding Only One Infringed
Law360 has reported that a Delaware federal jury has cleared Dexcom, represented by Keker, Van Nest & Peters, of infringing two glucose monitor patents owned by an Abbott Laboratories unit, while finding infrin…
Read More -
Google Settles AI-Chip Suit That Had Sought $1.6 Billion
Law360 has reported that Google LLC, represented by Keker, Van Nest & Peters, and Singular Computing LLC have settled a patent lawsuit over computer chip designs that improve efficiency for artificial intellige…
Read More -
Keker, Van Nest & Peters Promotes New Partners and Of Counsel
Keker, Van Nest & Peters is pleased to announce that the firm has elevated associates Andrew Bruns, Cody Gray, Maya James, Christina Lee, and Franco Muzzio to Partner, Kristen Lovin to Of Counsel and Senior IP …
Read More